BR0308567A - derivados de glicosìdeo e glicosìdeo de ortoéster de apomorfina, análogos, e seus usos - Google Patents
derivados de glicosìdeo e glicosìdeo de ortoéster de apomorfina, análogos, e seus usosInfo
- Publication number
- BR0308567A BR0308567A BRPI0308567-8A BR0308567A BR0308567A BR 0308567 A BR0308567 A BR 0308567A BR 0308567 A BR0308567 A BR 0308567A BR 0308567 A BR0308567 A BR 0308567A
- Authority
- BR
- Brazil
- Prior art keywords
- glycoside
- analogs
- apomorphine
- derivatives
- orthoester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36545402P | 2002-03-19 | 2002-03-19 | |
| PCT/US2003/008448 WO2003080074A1 (en) | 2002-03-19 | 2003-03-19 | Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0308567A true BR0308567A (pt) | 2007-01-09 |
Family
ID=28454658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0308567-8A BR0308567A (pt) | 2002-03-19 | 2003-03-19 | derivados de glicosìdeo e glicosìdeo de ortoéster de apomorfina, análogos, e seus usos |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060004190A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1496915A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005526790A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050008658A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1720054A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003223304A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0308567A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2479372A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003080074A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050090518A1 (en) * | 2003-10-24 | 2005-04-28 | Nastech Pharmaceutical Company Inc. | Method for treating parkinson's disease using apomorphine and apomorphine prodrugs |
| FR2939436B1 (fr) * | 2008-12-10 | 2010-12-17 | Sanofi Aventis | Synthese de morphine-6-glucuronide ou de l'un de ses derives |
| PT2952191T (pt) | 2009-06-12 | 2018-11-30 | Sunovion Pharmaceuticals Inc | Apomorfina sublingual |
| EP2651357B1 (en) | 2010-12-16 | 2020-04-01 | Sunovion Pharmaceuticals Inc. | Sublingual films |
| EP2854764B1 (en) | 2012-06-05 | 2018-12-12 | Neuroderm Ltd | Compositions comprising apomorphine and organic acids and uses thereof |
| KR20160108828A (ko) | 2013-11-11 | 2016-09-20 | 임팩스 라보라토리즈, 인코포레이티드 | 신속하게 붕괴되는 제형 및 사용 방법 |
| AU2015369554A1 (en) * | 2014-12-23 | 2017-08-03 | Neuroderm Ltd | Crystal forms of apomorphine and uses thereof |
| PT3713933T (pt) | 2017-11-24 | 2026-05-19 | H Lundbeck As | Novos profrmacos de catecolamina para utilizao no tratamento de doena de parkinson |
| US11104697B2 (en) | 2019-05-20 | 2021-08-31 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
| US11111263B2 (en) | 2019-05-20 | 2021-09-07 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
| US11130775B2 (en) | 2019-05-20 | 2021-09-28 | H. Lundbeck A/S | Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
| US11168056B2 (en) | 2019-05-20 | 2021-11-09 | H. Lundbeck A/S | Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol |
| EP3972600B1 (en) | 2019-05-21 | 2026-02-18 | H. Lundbeck A/S | Catecholamine carbamate prodrugs for use in the treatment of parkinson s disease |
| WO2020234275A1 (en) | 2019-05-21 | 2020-11-26 | H. Lundbeck A/S | New catecholamine prodrugs for use in the treatment of parkinson's diseases |
| US12391650B2 (en) | 2019-05-21 | 2025-08-19 | H. Lundbeck A/S | Catecholamine prodrugs for use in the treatment of Parkinson's disease |
| JP7641234B2 (ja) | 2019-05-21 | 2025-03-06 | ハー・ルンドベック・アクチエゼルスカベット | パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ |
| CN114773409B (zh) * | 2022-04-27 | 2023-12-15 | 江西艾立斯特生物科技有限公司 | 一种2,3,4,6-四-o-乙酰基-吡喃葡萄糖的制备方法 |
| EP4540257A1 (en) | 2022-06-15 | 2025-04-23 | EVER Neuro Pharma GmbH | Apomorphine prodrugs and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4785014A (en) * | 1985-06-07 | 1988-11-15 | Yale University | Use of clonidine in memory enhancement |
| DE69434304T2 (de) * | 1993-03-26 | 2005-12-29 | Merkus, Franciscus Wilhelmus H.M. | Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin |
| US6121276A (en) * | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| ATE312609T1 (de) * | 1994-04-22 | 2005-12-15 | Pentech Pharmaceuticals Inc | Sublinguale zusammensetzung enthaltend apomorphine zur diagnose der funktionellen impotenz |
| US5744476A (en) * | 1994-06-27 | 1998-04-28 | Interneuron Pharmaceuticals, Inc. | Dopamine D1 agonists for the treatment of dementia |
| US5562917A (en) * | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
| US5888534A (en) * | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
| GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
| US5945117A (en) * | 1998-01-30 | 1999-08-31 | Pentech Pharmaceuticals, Inc. | Treatment of female sexual dysfunction |
| US6001845A (en) * | 1998-06-19 | 1999-12-14 | Schering Corporation | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction |
| US6011043A (en) * | 1998-06-19 | 2000-01-04 | Schering Corporation | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction |
| US6266560B1 (en) * | 1998-06-19 | 2001-07-24 | Genetronics, Inc. | Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction |
| US5994363A (en) * | 1998-08-24 | 1999-11-30 | Pentech Pharmaceuticals, Inc. | Amelioration of apomorphine adverse effects |
| US6291471B1 (en) * | 1998-12-17 | 2001-09-18 | Abb Holdings, Inc. | Use of apomorphine for the treatment of organic erectile dysfunction in males |
| US6087362A (en) * | 1999-03-16 | 2000-07-11 | Pentech Pharmaceuticals, Inc. | Apomorphine and sildenafil composition |
| KR20030036157A (ko) * | 2000-04-07 | 2003-05-09 | 탭 파마슈티칼 프로덕츠 인코포레이티드 | 아포모르핀 유도체 및 이의 사용 방법 |
-
2003
- 2003-03-19 JP JP2003577900A patent/JP2005526790A/ja not_active Withdrawn
- 2003-03-19 US US10/508,160 patent/US20060004190A1/en not_active Abandoned
- 2003-03-19 BR BRPI0308567-8A patent/BR0308567A/pt not_active IP Right Cessation
- 2003-03-19 AU AU2003223304A patent/AU2003223304A1/en not_active Abandoned
- 2003-03-19 CN CNA038114879A patent/CN1720054A/zh active Pending
- 2003-03-19 CA CA002479372A patent/CA2479372A1/en not_active Abandoned
- 2003-03-19 EP EP03719419A patent/EP1496915A1/en not_active Withdrawn
- 2003-03-19 KR KR10-2004-7014649A patent/KR20050008658A/ko not_active Withdrawn
- 2003-03-19 WO PCT/US2003/008448 patent/WO2003080074A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1496915A1 (en) | 2005-01-19 |
| WO2003080074A1 (en) | 2003-10-02 |
| US20060004190A1 (en) | 2006-01-05 |
| JP2005526790A (ja) | 2005-09-08 |
| CA2479372A1 (en) | 2003-10-02 |
| AU2003223304A1 (en) | 2003-10-08 |
| CN1720054A (zh) | 2006-01-11 |
| KR20050008658A (ko) | 2005-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010002027A (es) | Derivados de bencilbenceno y metodos de uso. | |
| HN1999000124A (es) | Derivados de pirazol substituido. | |
| UY28150A1 (es) | Agentes terapeuticos | |
| MY138478A (en) | Benzazepine derivatives for the treatment of neurological disorders | |
| BRPI0410029B8 (pt) | composto dihidroquinazolina substituído, processo para sua preparação, medicamento compreendendo o referido composto e uso do referido composto | |
| TW200508223A (en) | Acylated piperazine derivatives as melanocortin-4 receptor agonists | |
| NO20033812D0 (no) | Acylerte piperidinderivater som melanokortin-4- reseptoragonister | |
| MX9703430A (es) | Uso de dioxomorfolinas para la lucha contra endoparasitos, nuevas dioxomorfolinas y procedimiento para su produccion. | |
| BRPI0512683A (pt) | compostos anti-virais | |
| BR0312232A (pt) | Inibidores de caspases e seus usos | |
| MXPA05011208A (es) | Uso de ivermectina para el tratamiento de desordenes dermatologicos. | |
| DE60215132D1 (de) | Acylierte piperidin-derivate als melanocortin-4-rezeptor-agonisten | |
| UY28144A1 (es) | Agentes terapéuticos | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| BR0212611A (pt) | Compostos de pirazolila substituìdos para o tratamento da inflamação | |
| ECSP055535A (es) | Derivados de 1-heterociclialquil-3-sulfonilazaindol o azaindol como ligandos de 5-hidroxitriptamina-6 | |
| UY28376A1 (es) | Agentes terapéuticos | |
| ECSP034810A (es) | Derivados heterociclilalcoxi-, -alquiltio- y - alquilaminobenzazol tales como ligandos 5-hidroxitriptamina-6 | |
| WO2008083200A3 (en) | Spiroheterocyclic glycosides and methods of use | |
| TW200514781A (en) | Novel compounds | |
| UY28945A1 (es) | Derivados de pirrolopiridina | |
| BRPI0411661A (pt) | derivados de n-fenil-piperazina e métodos de profilaxia ou tratamento de doenças associadas com o receptor 5ht 2c | |
| YU75603A (sh) | Dihidropirimidinska jedinjenja koja su supstituisana na cijano grupi i njihova upotreba u lečenju oboljenja | |
| BR0314195A (pt) | Derivados de piridina substituìda como agentes antitumorais | |
| UY28377A1 (es) | Agentes terapeuticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A, 6A, 7A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010. |